Skip to main content
. 2020 Nov;82(4):725–733. doi: 10.18999/nagjms.82.4.725

Table 2.

Overall responses

Response n ( % )
Complete response (CR) 1 ( 2.1 )
Partial response (PR) 7 ( 14.6 )
Stable disease (SD) 26 ( 54.2 )
Progressive disease (PD) 11 ( 22.9 )
Not evaluable (NE) 3 ( 6.3 )